2010, Number 2
<< Back Next >>
Acta Ortop Mex 2010; 24 (2)
Multimodal treatment of chronic unspecific low back pain
González MC, Moscoso LL, Ramírez EG, Abdo AA
Language: Spanish
References: 33
Page: 88-94
PDF size: 140.09 Kb.
ABSTRACT
A prospective longitudinal study was conducted using three multimodal treatment regimens that included a different NSAID for each of the regimens (thiaprofenic acid, piroxicam, meloxicam), a steroid (betamethasone) and a muscle relaxant (tetrazepam). 240 patients with a history of chronic low back pain for more than six months were treated; they were divided into three groups of 80 patients assigned to each regimen.
Results: Patients treated with thiaprophenic acid and meloxicam improved a total of 6 points, going from an initial mean score of 8 in the VAS at the onset of treatment, to a score of 2 at the end of treatment during a mean of 3 months. Patients treated with piroxicam had a 5-point improvement in the VAS, from a mean score of 7 at the onset of treatment to a mean score of 2 in a mean of 3 months.
Complications: The meloxicam group had less epigastric complications, 1.25% compared with 2.91% for the thiaprophenic acid group and 3.75% for piroxicam.
Conclusion: This combination, which includes an antiinflammatory agent, a steroid and a muscle relaxant, is an appropriate treatment regimen because it includes drugs that act on the antiinflammatory component, the pain component and the emotional component, which are the most common factors mentioned as probable causes of unspecific low back pain.
REFERENCES
Borenstein D. Epidemiology, Etiology, diagnosis, evaluation and treatment of low back pain. Curr Opin Rheumatol 1996; 8: 124-9.
Croft P, Papageorgiou A, Ferry S, Thomas E, Jayson M, Silman A: Psychological distress and low back Pain: evidence from a prospective study in the general population. Spine 1995; 20: 2731-7.
Speed C: Low back pain. BMJ 2004; 328: 1119-21.
Ranney D: Chronic musculoskeletal injuries in the workplaces. Philadelphia: W.B. Saunders Company, 1997: 101-13.
Boventry M, Zadine A: Self reported low back symptoms in urban drivers exposed to whole body vibration. Spine 1992: 1044-59.
Anderson G, Svensson H-O, Oden A: The intensity of work recovery in low back pain. Spine 1983; 8: 880-4.
Deyo R: Early diagnostic evaluation of low back pain. Gen Int Med 1986; 1: 328-38.
Fishbain D: Evidence – based data on pain relief with antidepressants. Ann Tat Med 2000; 32(5): 305-16.
Fordyce WE: Back pain in the workplace: Management of disability in nonspecific conditions. Task Force on pain in the Workplace. Seattle: IASP Press 1995.
Grupo Español de Trabajo del Programa Europeo COST B13.
Reddy S, Patt R: The benzodiazepines as adjuvant analgesics. Journal of Pain and Symptom Management 1994; 9: 510-4.
Atlas S, Deyo R: Evaluating and managing acute low back pain in the primary care setting. Gen Int Med 2001; 16: 120-31.
Balter MB, Levine J, Manheimer DI: Cross-national study of the extent of anti-anxiety/sedative drug use. N Engl J Med 1974; 290: 769-74.
Basmajian J: Cyclobenzaprine hydrochloride effect on skeletal muscle spasm in the lumbar region and neck: two double-blind controlled clinical and laboratory studies. Arch Phys Med Rehabil 1978; 59: 58-63.
Frymoyer J: Back pain and sciatica. N Engl J Med 1988; 318: 291-300.
Lapioque F, Mainard D, Gillet P, Payan E, Bannwarth B, Netter P: Stereoslective distribution of tiaprofenic acid in synovium and cartilage in osteoarthritic patients. Eur J Clin Pharmacol 1996; 50(4): 283.
Michele C, Battie J, Stanley J: Industrial back pain complaints. A Broader perspective. Orthop Clin North Am 1991: 273-82.
Van Tulder MW, Touray T, Furlan AD, et al: Muscle relaxants for non-specific low back pain. Spine 2003; 28: 2540-5.
Adraiensen H, Gybels J, Handwerker HO, Hess I: Latencies of chemically evoked discharges in human cutaneous nociceptors and of the concurrent subjective sensations. Neurosci Lett 1980; 20: 55-60.
Besson JM, Chaouch A: Peripheral and spinal mechanism of nociception. Physiological Reviews 1987: 67-186.
Benzon H: Epidural steroid injections for low back pain and lumbosacral radiculopathy. Pain 1986; 24: 277-95.
Bigos S, Bowyer O, Braen G: Acute low back problems in adults. Clinical Practice Guidelines no. 14. Rockville, MD, Department of Health an Human Services, 1994, AHCPR Publication No. 95-0642:
Bugedo G, Dagnino J, Muñoz H, Torregrosa S: Escala visual análoga: Comparación de seis escalas distintas. Rev Chil Anestesia 1989; 18: 132.
Bonica JJ: Anatomic and physiologic basis of nociception of pain. En: Bonica JJ. The management of pain. 2a ed. 1990. Lea & Fabiger; Philadelphia: 28-94.
Carette S, Marcoux S, Truchon R, Grandin C, Cagnon J, Allard Y, Latulippe M: A controlled trial of corticosteroid injections into facet joints for chronic low pain. N Engl J Med 1991: 1002-7.
Ceraso OL: Temas sobre el dolor. Bagó Informa 1981; XII(31): 13-28.
Churchill L, Graham AG, Shih CK, Pauletti D, Farina PR, Grob PM: Selective inhibition of human cyclo-oxygenase-2 by meloxicam. Inflammopharmacol 1966; 4: 125-35.
Davies NM: Clinical pharmacokinet of tiaprofenic acid and its enantiomers. Clin Pharmacokinet 1996; 31(5): 331-47.
Deyo R, James N W Einstein; Low Back Pain. N Engl J Med 2001; 344, 363-70.
Engelhardt G: Meloxicam inhibits preferentially COX-2. Eur J Clin Pharmacol 1994; 47: A98.
Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzier C: Anti-inflammatory, analgesic, antipyretic an related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res 1955; 44: 423-33.
Rives PA, Douglass AB: Evaluation and treatment of low back pain in family practice. J Am Board Fam Pract 2004; 17: S23-31.
Stephen D, Kuslich C, Ulstrom RN, Cami JM: The tissue origin of low bank pain and sciatica. Orthop Clin North Am 1991: 181-7.
Full text